HYDI Hydromer Inc.

Hydromer Inc. is Pleased to Announce the Addition of a New Global Business Development Manager to Propel Growth

Hydromer Inc. is Pleased to Announce the Addition of a New Global Business Development Manager to Propel Growth

Concord, NC, June 29, 2021 (GLOBE NEWSWIRE) -- via -- Hydromer, Inc. (the “Company”) (HYDI:OTC) is pleased to announce that Mr. Craig Hughes has recently joined the Hydromer family in the capacity of Global Business Development Manager reporting to Ravi Rangarajan, Vice President, Sales & Business Development. Mr. Hughes is a seasoned veteran in the chemical industry with extensive knowledge of Coatings and Adhesives among other products. He has multi-faceted experience gained through Product Development, Sales and Business Development roles at well-known global companies. Craig’s academic background is impressive and includes a Ph.D in Organic Chemistry from the University of Florida and a Post Doctoral Research Fellow at the University of Birmingham UK. His most recent professional background includes the positions of Business Development Manager with EMD Performance Materials Corporation, Sales Development roles with Siltech Corporation and Evonik Corporation, and Business Development and R&D Group Leader positions with Clariant Corporation. 

“The addition of this proven industry veteran will further empower Hydromer in taking a more aggressive approach in the vast specialty polymer and surface coatings market.  Hydromer is better positioned to expand and grow upon our proven solutions for various applications in the medical and healthcare segments,” said Ravi Rangarajan, VP Sales & Marketing, Hydromer.

Hydromer, Inc. is an innovative ISO 9001:2015 technology-focused company engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer-based Coatings for Medical Device, Health Care, and Industrial market segments. Hydromer also provides highly specialized medical coating services and coating equipment, is FDA registered and ISO 13485 & ISO9001 certified.

For the latest information about Hydromer, Inc. and its products, please visit our web site at 

Ravi Rangarajan

(908) 722-5000 Ext. 214



EN
29/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hydromer Inc.

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Thi...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended September 30, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-end ...

 PRESS RELEASE

Hydromer, Inc. Announces the Restructuring and Formation of World-Clas...

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development ·       Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions ·       Restructured R&D division, under new leadership, aims to enhance product offerings, improve operational efficiency, and drive future growth CONCORD, N.C. , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologie...

 PRESS RELEASE

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Fin...

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to ch...

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Fir...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-en...

 PRESS RELEASE

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Co...

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations CONCORD, NC, Jan. 16, 2024 (GLOBE NEWSWIRE) -- via – Hydromer, Inc. (OTC: HYDI) Hydromer, Inc. (the “Company”) is pleased to provide the following update to shareholders regarding the Company’s progress toward stability and profitable growth. Much has been done since the spring of 2023 in reducing the Company’s overhead and operating costs, which management believes will lead to improved profitability in the current fiscal year. Additionally, investment in new prod...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch